Literature DB >> 25817394

Long-term controlled delivery of rhBMP-2 from collagen-hydroxyapatite scaffolds for superior bone tissue regeneration.

Elaine Quinlan1, Emmet M Thompson1, Amos Matsiko1, Fergal J O'Brien1, Adolfo López-Noriega2.   

Abstract

The clinical utilization of recombinant human bone morphogenetic protein 2 (rhBMP-2) delivery systems for bone regeneration has been associated with very severe side effects, which are due to the non-controlled and non-targeted delivery of the growth factor from its collagen sponge carrier post-implantation which necessitates supraphysiological doses. However, rhBMP-2 presents outstanding regenerative properties and thus there is an unmet need for a biocompatible, fully resorbable delivery system for the controlled, targeted release of this protein. With this in mind, the purpose of this work was to design and develop a delivery system to release low rhBMP-2 doses from a collagen-hydroxyapatite (CHA) scaffold which had previously been optimized for bone regeneration and recently demonstrated significant healing in vivo. In order to enhance the potential for clinical translation by minimizing the design complexity and thus upscaling and regulatory hurdles of the device, a microparticle and chemical functionalization-free approach was chosen to fulfill this aim. RhBMP-2 was combined with a CHA scaffold using a lyophilization fabrication process to produce a highly porous CHA scaffold supporting the controlled release of the protein over the course of 21days while maintaining in vitro bioactivity as demonstrated by enhanced alkaline phosphatase activity and calcium production by preosteoblasts cultured on the scaffold. When implanted in vivo, these materials demonstrated increased levels of healing of critical-sized rat calvarial defects 8weeks post-implantation compared to an empty defect and unloaded CHA scaffold, without eliciting bone anomalies or adjacent bone resorption. These results demonstrate that it is possible to achieve bone regeneration using 30 times less rhBMP-2 than INFUSE®, the current clinical gold standard; thus, this work represents the first step of the development of a rhBMP-2 eluting material with immense clinical potential.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bone tissue regeneration; Collagen–hydroxyapatite; Controlled release; Osteogenesis; Rat calvarial defect model; RhBMP-2

Mesh:

Substances:

Year:  2015        PMID: 25817394     DOI: 10.1016/j.jconrel.2015.03.028

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  29 in total

1.  Capsule-Integrated Polypeptide Multilayer Films for Effective pH-Responsive Multiple Drug Co-Delivery.

Authors:  Shichao Zhang; Malcolm Xing; Bingyun Li
Journal:  ACS Appl Mater Interfaces       Date:  2018-12-14       Impact factor: 9.229

2.  Effect of bone sialoprotein coating on progression of bone formation in a femoral defect model in rats.

Authors:  Anja Klein; Andreas Baranowski; Ulrike Ritz; Christiane Mack; Hermann Götz; Eva Langendorf; Bilal Al-Nawas; Philipp Drees; Pol M Rommens; Alexander Hofmann
Journal:  Eur J Trauma Emerg Surg       Date:  2019-05-28       Impact factor: 3.693

Review 3.  Treatment of critical-sized bone defects: clinical and tissue engineering perspectives.

Authors:  Erika Roddy; Malcolm R DeBaun; Adam Daoud-Gray; Yunzhi P Yang; Michael J Gardner
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-10-28

4.  Testing a novel nanofibre scaffold for utility in bone tissue regeneration.

Authors:  R Nicole Howie; Emily Durham; Brayden Oakes; Zachary Grey; Jason Smith; Phil Campbell; Amanda LaRue; Martin Steed; Robin Muise-Helmericks; James Cray
Journal:  J Tissue Eng Regen Med       Date:  2018-08-29       Impact factor: 3.963

5.  The influence of cyclic tensile strain on multi-compartment collagen-GAG scaffolds for tendon-bone junction repair.

Authors:  William K Grier; Raul A Sun Han Chang; Matthew D Ramsey; Brendan A C Harley
Journal:  Connect Tissue Res       Date:  2019-04-22       Impact factor: 3.417

6.  An efficient, non-viral dendritic vector for gene delivery in tissue engineering.

Authors:  D P Walsh; A Heise; F J O'Brien; S-A Cryan
Journal:  Gene Ther       Date:  2017-09-14       Impact factor: 5.250

Review 7.  Controlled drug release for tissue engineering.

Authors:  Kunal J Rambhia; Peter X Ma
Journal:  J Control Release       Date:  2015-08-29       Impact factor: 9.776

8.  Prolonged delivery of BMP-2 by a non-polymer hydrogel for bone defect regeneration.

Authors:  Mathieu Maisani; K R Sindhu; Mathilde Fenelon; Robin Siadous; Sylvie Rey; Diego Mantovani; Olivier Chassande
Journal:  Drug Deliv Transl Res       Date:  2018-02       Impact factor: 4.617

Review 9.  Supramolecular self-assembling peptides to deliver bone morphogenetic proteins for skeletal regeneration.

Authors:  Charlotte H Chen; Erin L Hsu; Samuel I Stupp
Journal:  Bone       Date:  2020-07-31       Impact factor: 4.398

10.  MSC-Derived Extracellular Vesicles in Preclinical Animal Models of Bone Injury: A Systematic Review and Meta-Analysis.

Authors:  Aidan M Kirkham; Adrian J M Bailey; Alvin Tieu; Harinad B Maganti; Joshua Montroy; Risa Shorr; T Mark Campbell; Dean A Fergusson; Manoj M Lalu; Heidi Elmoazzen; David S Allan
Journal:  Stem Cell Rev Rep       Date:  2021-07-27       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.